Author Archives: Natalie Themm
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer
Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday.
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost economics for Medicare population.
Xenter, the World’s First “TechMed” Company, Unveils the XenFI Wireless Network
Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem.
Multi-Center Liquid Embolic Study Concludes
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
Excess Equipment Sale for BioUtah Members
Excess Equipment Sale for BioUtah Members
FDA Clears Xenocor’s Saberscope, the World’s First Single-use 5mm Laparoscope with Auto-Focus
FDA Clears World’s First Single-use 5mm Laparoscope with Auto-Focus
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy
The European Commission’s approval of a novel gene therapy for severe hemophilia A has paved the way for use of a companion diagnostic in the European Union (EU).
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights
Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.
nView s1 reaches its 100th surgery
The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation.
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
